Trained as a computational biologist, I conduct genomic research to understand human gut microbiome at the Broad Institute. I use computational and statistical approaches with big data to explain how microorganisms in the gut cause disease. Before I joined the Broad Institute, I worked at Hebrew SeniorLife and Harvard Medical School, and I conducted genetic research to identify genetic markers of musculoskeletal diseases such as osteoporosis. I studied liver cancer genome when I worked at Eli Lilly as a research intern, and my Ph.D. projects focused on improvement of biofuels production by genetically modified bacteria and plant cell wall.